Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 2,085

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Prebiotic effects: metabolic and health benefits

Open access
Roberfroid, Marcel, Gibson, Glenn R., Hoyles, Lesley, McCartney, Anne L., Rastall, Robert, Rowland, Ian, Wolvers, Danielle, Watzl, Bernhard, Szajewska, Hania, Stahl, Bernd, Guarner, Francisco, Respondek, Frederique, Whelan, Kevin, Coxam, Veronique, Davicco, Marie-Jeanne, Léotoing, Laurent, Wittrant, Yohann, Delzenne, Nathalie M., Cani, Patrice D., Neyrinck, Audrey M., Meheust, Agnes·2010·British Journal of Nutrition
DOI 10.1017/s0007114510003363
Open this paper in CoChat — free account

Abstract

The different compartments of the gastrointestinal tract are inhabited by populations of micro-organisms. By far the most important predominant populations are in the colon where a true symbiosis with the host exists that is a key for well-being and health. For such a microbiota, ‘normobiosis’ characterises a composition of the gut ‘ecosystem’ in which micro-organisms with potential health benefits predominate in number over potentially harmful ones, in contrast to ‘dysbiosis’, in which one or a few potentially harmful micro-organisms are dominant, thus creating a disease-prone situation. The present document has been written by a group of both academic and industry experts (in the ILSI Europe Prebiotic Expert Group and Prebiotic Task Force, respectively). It does not aim to propose a new definition of a prebiotic nor to identify which food products are classified as prebiotic but rather to validate and expand the original idea of the prebiotic concept (that can be translated in ‘prebiotic effects’), defined as: ‘The selective stimulation of growth and/or activity(ies) of one or a limited number of microbial genus(era)/species in the gut microbiota that confer(s) health benefits to the host.’ Thanks to the methodological and fundamental research of microbiologists, immense progress has very recently been made in our understanding of the gut microbiota. A large number of human intervention studies have been performed that have demonstrated that dietary consumption of certain food products can result in statistically significant changes in the composition of the gut microbiota in line with the prebiotic concept. Thus the prebiotic effect is now a well-established scientific fact. The more data are accumulating, the more it will be recognised that such changes in the microbiota's composition, especially increase in bifidobacteria, can be regarded as a marker of intestinal health. The review is divided in chapters that cover the major areas of nutrition research where a prebiotic effect has tentatively been investigated for potential health benefits. The prebiotic effect has been shown to associate with modulation of biomarkers and activity(ies) of the immune system. Confirming the studies in adults, it has been demonstrated that, in infant nutrition, the prebiotic effect includes a significant change of gut microbiota composition, especially an increase of faecal concentrations of bifidobacteria. This concomitantly improves stool quality (pH, SCFA, frequency and consistency), reduces the risk of gastroenteritis and infections, improves general well-being and reduces the incidence of allergic symptoms such as atopic eczema. Changes in the gut microbiota composition are classically considered as one of the many factors involved in the pathogenesis of either inflammatory bowel disease or irritable bowel syndrome. The use of particular food products with a prebiotic effect has thus been tested in clinical trials with the objective to improve the clinical activity and well-being of patients with such disorders. Promising beneficial effects have been demonstrated in some preliminary studies, including changes in gut microbiota composition (especially increase in bifidobacteria concentration). Often associated with toxic load and/or miscellaneous risk factors, colon cancer is another pathology for which a possible role of gut microbiota composition has been hypothesised. Numerous experimental studies have reported reduction in incidence of tumours and cancers after feeding specific food products with a prebiotic effect. Some of these studies (including one human trial) have also reported that, in such conditions, gut microbiota composition was modified (especially due to increased concentration of bifidobacteria). Dietary intake of particular food products with a prebiotic effect has been shown, especially in adolescents, but also tentatively in postmenopausal women, to increase Ca absorption as well as bone Ca accretion and bone mineral density. Recent data, both from experimental models and from human studies, support the beneficial effects of particular food products with prebiotic properties on energy homaeostasis, satiety regulation and body weight gain. Together, with data in obese animals and patients, these studies support the hypothesis that gut microbiota composition (especially the number of bifidobacteria) may contribute to modulate metabolic processes associated with syndrome X, especially obesity and diabetes type 2. It is plausible, even though not exclusive, that these effects are linked to the microbiota-induced changes and it is feasible to conclude that their mechanisms fit into the prebiotic effect. However, the role of such changes in these health benefits remains to be definitively proven. As a result of the research activity that followed the publication of the prebiotic concept 15 years ago, it has become clear that products that cause a selective modification in the gut microbiota's composition and/or activity(ies) and thus strengthens normobiosis could either induce beneficial physiological effects in the colon and also in extra-intestinal compartments or contribute towards reducing the risk of dysbiosis and associated intestinal and systemic pathologies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s0007114510003363

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 426

  1. 10.1124/dmd.106.010645 · DOI
  2. 10.1016/j.nut.2006.05.010 · DOI
  3. Mathey, 2008, Improvement of bone-sparing effect of soy isoflavones by pre-and probiotics in postmenopausal women, Clinl Med Women's Health, 1, 15
  4. 10.1016/j.nut.2009.04.014 · DOI
  5. Klobukowski, 2009, Calcium bioavailability from diets based on white cheese containing probiotics or synbiotics in short-time study in rats, Pakistan J Nutr, 8, 933, 10.3923/pjn.2009.933.936 · DOI
  6. 10.1016/j.foodchem.2008.08.062 · DOI
  7. 10.1093/jn/136.1.117 · DOI
  8. 10.1016/j.nut.2005.12.013 · DOI
  9. 10.1186/1475-2891-4-29 · DOI
  10. 10.1079/BJN2001430 · DOI
  11. 10.3177/jnsv.43.123 · DOI
  12. 10.1016/j.nut.2008.08.002 · DOI
  13. Rondon, 2008, Dietary inulin in mice stimulates Mg2+ absorption and modulates TRPM6 and TRPM7 expression in large intestine and kidney, Magnes Res, 21, 224
  14. 10.1017/S0007114508894378 · DOI
  15. 10.1016/j.nutres.2006.06.019 · DOI
  16. 10.1016/j.bone.2005.09.006 · DOI
  17. 10.1007/s00394-006-0592-0 · DOI
  18. 10.1079/BJN20051483 · DOI
  19. 10.1093/jn/134.2.399 · DOI
  20. 10.1271/bbb.59.236 · DOI
  21. 10.1258/mi.2009.009008 · DOI
  22. 10.1097/01.NT.0000303311.36663.39 · DOI
  23. 10.1111/j.1467-3010.2008.00710.x · DOI
  24. 10.1093/jn/137.11.2513S · DOI
  25. 10.1093/jn/137.11.2527S · DOI
  26. 10.1016/j.idairyj.2005.10.028 · DOI
  27. 10.1111/j.1467-3010.2006.00584.x · DOI
  28. Caers, 2003, The role of prebiotic fibres in the process of calcium absorption, Dietary Fibre Congress – Conference Proceedings, 46
  29. Cashman, 2003, Prebiotics and calcium bioavailability, Curr Issues Intest Microbiol, 4, 21
  30. Coudray, 2004, Dietary fibers and mineral absorption: the case of magnesium, Agro Food Industry Hi-Tech, 15, 40
  31. 10.1081/FRI-120025482 · DOI
  32. 10.1007/BF02708379 · DOI · Paper page
  33. 10.1079/BJN/2002529 · DOI
  34. Franck, 2000, Functional Foods, 108
  35. 10.1093/jn/137.11.2503S · DOI
  36. 10.1097/01.mib.0000235828.09305.0c · DOI
  37. 10.1111/j.1365-277X.1990.tb00244.x · DOI
  38. 10.1073/pnas.0706625104 · DOI · Paper page
  39. 10.1086/420823 · DOI
  40. 10.1053/j.gastro.2007.11.059 · DOI · Paper page
  41. 10.1210/en.2004-0089 · DOI
  42. 10.1080/00365520801943354 · DOI
  43. 10.1093/bmb/ldn031 · DOI
  44. 10.1079/BJN20041289 · DOI
  45. 10.1093/jn/133.6.1903 · DOI
  46. 10.1136/gut.2005.081950b · DOI · Paper page
  47. 10.1113/expphysiol.1991.sp003530 · DOI
  48. 10.1017/S000711450779894X · DOI · Paper page
  49. 10.3748/wjg.15.2887 · DOI · Paper page
  50. 10.1021/jf062814q · DOI
  51. 10.1093/jn/129.1.113 · DOI · Paper page
  52. 10.1016/S0895-4356(99)00018-9 · DOI
  53. 10.1016/S0016-5085(00)85255-5 · DOI
  54. 10.1016/j.lfs.2006.05.013 · DOI
  55. 10.1093/ajcn/75.2.254 · DOI
  56. de Vrese, 2008, Probiotics, prebiotics, and synbiotics, Adv Biochem Eng Biotechnol, 111, 1
  57. 10.3748/wjg.15.2081 · DOI
  58. 10.1016/j.nut.2005.02.011 · DOI
  59. 10.1093/jn/137.11.2563S · DOI
  60. 10.1111/j.1365-2222.2007.02849.x · DOI
  61. 10.1016/S1542-3565(04)00677-9 · DOI
  62. 10.1051/medsci/2008245505 · DOI
  63. 10.1016/j.jpeds.2006.04.053 · DOI
  64. 10.1136/gut.2004.044834 · DOI · Paper page
  65. Perrin, 2003, Oligofructose does not affect the development of Type 1 diabetes mellitus induced by dietary proteins in the diabetes-prone BB rat model, Diab Nutr Metabol, 16, 94
  66. 10.1159/000087637 · DOI
  67. 10.1079/NRR200479 · DOI
  68. Dughera, 2007, Effects of synbiotic preparations on constipated irritable bowel syndrome symptoms, Acta Biomed, 78, 111
  69. 10.1046/j.1365-2036.2002.01318.x · DOI · Paper page
  70. 10.1136/bmj.324.7350.1361 · DOI · Paper page
  71. 10.1016/S1521-6918(03)00054-4 · DOI
  72. 10.1093/jn/137.11.2420 · DOI
  73. 10.1016/j.clnu.2009.01.008 · DOI
  74. 10.1079/BJN20031088 · DOI
  75. 2006, Official J Eur Union, L401, 1
  76. 10.1097/MPG.0b013e31817b6dd2 · DOI
  77. 10.1007/BF02071409 · DOI
  78. 10.1067/mai.2001.111237 · DOI · Paper page
  79. 10.1079/BJN/2002539 · DOI
  80. 10.3748/wjg.14.6564 · DOI
  81. Irvine, 1997, Quality of life issues in patients with inflammatory bowel disease, Am J Gastroenterol, 92, 18S
  82. Sakaguchi, 1998, Caecal fermentation and energy accumulation in the rat fed on indigestible oligosaccharides, Br J Nutr, 80, 469, 10.1017/S0007114598001548 · DOI
  83. 10.1093/jn/133.1.1 · DOI
  84. 10.1093/jn/138.9.1818S · DOI
  85. 10.1097/00005176-200411000-00003 · DOI
  86. 10.1203/01.pdr.0000198773.40937.61 · DOI
  87. Gray, 2006, Dietary Fibre: Definition, Analysis, Physiology and Health
  88. 10.1023/B:DDAS.0000026302.92898.ae · DOI
  89. 10.1128/JCM.02600-05 · DOI
  90. 10.1053/gast.2002.35394 · DOI
  91. 10.1093/ajcn/86.5.1426 · DOI
  92. 10.1093/jn/138.6.1141 · DOI
  93. 10.2220/biomedres.30.149 · DOI · Paper page
  94. 10.1093/ajcn/77.4.937 · DOI
  95. Kelly, 2009, Inulin-type prebiotics: a review (Part 2), Altern Med Rev, 14, 36
  96. Hudson, 1995, Human Colonic Bacteria: Role in Nutrition, Physiology and Pathology, 61
  97. 10.1073/pnas.0804812105 · DOI · Paper page
  98. 10.1097/01.mpg.0000221887.28877.c7 · DOI
  99. 10.1007/s00394-003-0390-x · DOI
  100. 10.1111/j.1399-3038.2005.00370.x · DOI
  101. 10.1079/BJN/2002529 · DOI
  102. 10.1136/gut.2004.043372 · DOI · Paper page
  103. 10.3109/10408448509041324 · DOI
  104. 10.1177/0148607195019005365 · DOI
  105. 10.1007/s11894-008-0106-8 · DOI
  106. 10.1093/jn/128.10.1815 · DOI
  107. 10.1136/gut.22.9.763 · DOI · Paper page
  108. 10.1136/gut.2009.208934c · DOI
  109. Griffin, 2007, Handbook of Prebiotics, 93
  110. 10.1017/S0029665107005563 · DOI
  111. 10.1038/35079107 · DOI · Paper page
  112. Hussey, 2003, Nutrition therapy in pediatric Crohn's disease patients improves nutritional status and decreases inflammation, J Pediatr Gastroenterol Nutr, 37
  113. 10.1152/physrev.2001.81.3.1031 · DOI · Paper page
  114. Rowland, 1995, Human Colonic Bacteria, Role in Nutrition, Physiology and Pathology, 155
  115. 10.1099/jmm.0.46189-0 · DOI
  116. Quigley, 1995, Human Colonic Bacteria: Role in Nutrition, Physiology and Pathology, 175
  117. Hanai, 2004, Germinated barley foodstuff prolongs remission in patients with ulcerative colitis, Int J Mol Med, 13, 643
  118. 10.1021/pr8009885 · DOI
  119. 10.1016/j.trsl.2006.11.009 · DOI · Paper page
  120. Ohta, 1994, Effects of fructooligosaccharides on the absorption of magnesium and calcium by cecectomized rats, Int J Vitam Nutr Res, 64, 316
  121. 10.1159/000012804 · DOI
  122. 10.1016/S0006-291X(03)00488-1 · DOI · Paper page
  123. 10.1016/S0271-5317(01)00354-2 · DOI
  124. 10.2174/138161209788168191 · DOI
  125. 10.1053/j.gastro.2004.01.063 · DOI
  126. 10.1093/carcin/22.1.127 · DOI
  127. 10.1111/j.1753-4887.2006.tb00201.x · DOI
  128. 10.1079/BJN2003950 · DOI
  129. Macfarlane, 1995, Human Colonic Bacteria: Role in Nutrition, Physiology and Pathology, 75
  130. 10.1002/jsfa.2740370717 · DOI
  131. 10.1017/S0007114507730751 · DOI
  132. 10.1128/AEM.71.8.4777-4783.2005 · DOI
  133. 10.1136/gut.35.3.353 · DOI
  134. Schaafsma, 1997, Bioavailability of calcium and magnesium, Eur J Clin Nutr, 51, S13
  135. Cashman, 2002, Probiotics and Prebiotics: Where Are We going?, 149
  136. 10.1046/j.1365-2036.2001.01043.x · DOI
  137. O'Connor, 2005, Probiotic Dairy Products, 167
  138. 10.1359/jbmr.2001.16.11.2152 · DOI
  139. 10.1097/00005176-200409000-00003 · DOI
  140. 10.1159/000146350 · DOI
  141. Zoetendal, 1998, Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria, Appl Environ Microbiol, 64, 3854, 10.1128/AEM.64.10.3854-3859.1998 · DOI · Paper page
  142. 10.1136/gut.2007.119446 · DOI · Paper page
  143. 10.1079/BJN20041357 · DOI · Paper page
  144. Macfarlane, 1992, Comparison of fermentation reactions in different regions of the human colon, J Appl Bacteriol, 72, 57
  145. 10.1046/j.1365-2036.2001.01093.x · DOI
  146. Harmsen, 1999, A 16S rRNA-targeted probe for detection of lactobacilli and enterococci in fecal samples by fluorescent in situ hybridization, Microb Ecol Health Dis, 11, 3, 10.1080/089106099435862 · DOI
  147. 10.1093/jn/130.5.1197 · DOI
  148. 10.1128/AEM.68.6.2982-2990.2002 · DOI · Paper page
  149. 10.1177/153537020322800606 · DOI
  150. 10.12938/bifidus1982.2.1_3 · DOI
  151. 10.1093/ajcn/83.2.310 · DOI
  152. 10.1006/anae.2002.0434 · DOI
  153. 10.1093/jn/130.6.1572 · DOI
  154. 10.1079/BJN20051469 · DOI · Paper page
  155. Roberfroid, 2007, Inulin and oligofructose: proven health benefits and claims, J Nutr, 137, S2489
  156. Cummings, 1995, Human Colonic Bacteria: Role in Nutrition, Physiology and Pathology, 101
  157. 10.1007/s00394-008-0736-5 · DOI
  158. 10.1093/jn/131.3.787 · DOI
  159. 140 Osborn DA & Sinn JK (2007) Prebiotics in infants for prevention of allergic disease and food hypersensitivity. The Cochrane Database of Systematic Reviews 2007 , CD006474. · DOI
  160. 10.1080/07315724.2005.10719440 · DOI
  161. 10.1079/BJN20051451 · DOI
  162. 10.3945/ajcn.2009.28095 · DOI
  163. 10.1046/j.1365-2672.2003.02005.x · DOI
  164. Engelhardt, 1991, Short-Chain Fatty Acids: Metabolism and Clinical Importance, 60
  165. Fava, 2006, The gut microbiota and lipid metabolism: implications for human health and coronary heart disease, Curr Med Chem, 13, 3005, 10.2174/092986706778521814 · DOI
  166. 10.1136/gut.52.2.237 · DOI · Paper page
  167. Ng, 2008, Effective probiotic treatment (VSL# 3), but not placebo, in acute ulcerative colitis is associated with down-regulation of inflammatory intestinal dendritic cells, Gut, 57, A37
  168. 10.1093/ajcn/63.6.939 · DOI
  169. 10.1097/01.MIB.0000183421.02316.d5 · DOI
  170. 10.1016/j.chom.2008.02.015 · DOI · Paper page
  171. 10.1080/01635589609514461 · DOI
  172. Roberfroid, 1997, Dietary Fiber in Health and Disease
  173. 10.3945/ajcn.2008.26701 · DOI
  174. 10.3177/jnsv.41.281 · DOI
  175. 10.1099/jmm.0.45935-0 · DOI
  176. 10.1146/annurev.physiol.70.113006.100506 · DOI · Paper page
  177. 10.1111/j.1365-2036.2005.02304.x · DOI
  178. 10.1016/S0005-2760(98)00174-X · DOI
  179. 10.1111/j.1365-2036.2005.02624.x · DOI
  180. 10.3177/jnsv.44.465 · DOI
  181. 10.1111/j.1365-2672.2005.02783.x · DOI
  182. 10.1093/jn/134.2.479 · DOI
  183. Wada, 1992, Effects of soybean oligosaccharides in a beverage on human fecal flora and metabolites, J Agric Chem Soc Japan, 66, 127
  184. Siong, 2004, Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41, PNAS, 4, 1045
  185. 10.1677/joe.1.06100 · DOI · Paper page
  186. 10.1016/j.immuni.2009.08.020 · DOI · Paper page
  187. 10.1126/science.1110591 · DOI · Paper page
  188. 10.1017/CBO9780511754913.005 · DOI
  189. Zoetendal, 2001, The host genotype affects the bacterial community in the human gastrointestinal tract, Microb Ecol Health Dis, 13, 129, 10.1080/089106001750462669 · DOI · Paper page
  190. 10.1093/jn/121.11.1730 · DOI · Paper page
  191. 10.12938/bifidus1982.2.1_17 · DOI
  192. 10.1093/ajcn/72.6.1570 · DOI
  193. 10.1093/jn/138.6.1091 · DOI
  194. 10.1097/MPG.0b013e318164d920 · DOI
  195. Girrbach, 2005, Short- and long-term supplementation of pre- and probiotics modulate T-cell mediated immunity of the porcine GALT, FASEB J, 19, A444
  196. 10.1136/adc.2006.098251 · DOI
  197. 10.1111/j.1365-2982.2006.00853.x · DOI · Paper page
  198. Brommage, 1993, Intestinal calcium absorption in rats is stimulated by dietary lactulose and other resistant sugars, J Nutr, 123, 2186, 10.1093/jn/123.12.2186 · DOI
  199. 10.1055/s-2005-861160 · DOI
  200. Ben, 2004, Supplementation of milk formula with galacto-oligosaccharides improves intestinal micro-flora and fermentation in term infants, Chin Med J (Engl), 117, 927

200 of 426 shown

Cited by

See all 2,085

Metadata

Authors
Roberfroid, M., Gibson, G. R., Hoyles, L., McCartney, A. L., Rastall, R., Rowland, I., Wolvers, D., Watzl, B., Szajewska, H., Stahl, B., Guarner, F., Respondek, F., Whelan, K., Coxam, V., Davicco, M.-J., Léotoing, L., Wittrant, Y., Delzenne, N. M., Cani, P. D., Neyrinck, A. M., & Meheust, A.
Venue
British Journal of Nutrition
Publisher
Cambridge University Press (CUP)
Published
2010-08
Volume
104
Issue
S2
Pages
S1-S63
ISSN
  • 0007-1145 (ISSN-L)
  • 1475-2662
DOI
10.1017/s0007114510003363
OpenAlex
W2150326634
Cited by
2,085
References
37
FWCI
81.89
Type
journal article
Language
en
Open access
bronze
Licence
www.cambridge.org/core/terms (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.